Advances in the diagnosis of pathological response by a second biopsy in breast cancer neoadjuvant therapy and their clinical significance
With the development of neoadjuvant therapy, the pathological complete response rate has significantly increased for breast cancer patients.Theoretically, the use of locoregional radiotherapy instead of surgery is available for patients with pathological complete response, thus it is essential to pr...
Main Author: | XU Bingqi, ZHANG Guoqiang |
---|---|
Format: | Article |
Language: | English |
Published: |
Editorial Office of China Oncology
2022-04-01
|
Series: | Zhongguo aizheng zazhi |
Subjects: | |
Online Access: | http://www.china-oncology.com/fileup/1007-3639/PDF/1651908595636-467605702.pdf |
Similar Items
-
Deep learning-based predictive model for pathological complete response to neoadjuvant chemotherapy in breast cancer from biopsy pathological images: a multicenter study
by: Huancheng Zeng, et al.
Published: (2024-01-01) -
Organoids from patient biopsy samples can predict the response of BC patients to neoadjuvant chemotherapy
by: Dan Shu, et al.
Published: (2022-12-01) -
Correlation of an immune-related 8-gene panel with pathologic response to neoadjuvant chemotherapy in patients with primary breast cancers
by: Ling-Ming Tseng, et al.
Published: (2023-12-01) -
Clinicopathological Factors Determining the Pathological Response to Neoadjuvant Therapy in HER2 Positive Breast Cancer
by: Abdullah Evren YETİŞİR, et al.
Published: (2021-08-01) -
Nomograms for Predicting Disease-Free Survival Based on Core Needle Biopsy and Surgical Specimens in Female Breast Cancer Patients with Non-Pathological Complete Response to Neoadjuvant Chemotherapy
by: Ailin Lan, et al.
Published: (2023-01-01)